Gene · 442918
Papers2,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Self-assembled palindromic DNA nanostructure for orthogonal entropy-driven amplification and multiplexed fluorescence fingerprinting of intracellular RNAs. | Biosens Bioelectron | 2026 | 42541843 | PubTator, text mining | PubMed |
| Extracellular vesicle-derived miR-141, miR-10b, miR-550a and miR-16 define a circulating signature in prostate cancer. | Ir J Med Sci | 2026 | 42277406 | PubTator, text mining | PubMed |
| Heterogeneity of miRNAs in Salivary Gland Neoplasms: An Exploratory Pilot Study. | J Oral Pathol Med | 2026 | 42184999 | PubTator, text mining | PubMed |
| INTEGRATED ANALYSIS OF ERΑ, TP53, AND PGR PROTEINS WITH MIR-372, MIR-373, AND MIR-519D DYSREGULATION IN FEMALE BREAST CANCER. | Georgian Med News | 2026 | 42107952 | PubTator, text mining | PubMed |
| Insight into the potential significance of miR-760 and miR-1973 in breast cancer: a comprehensive analysis. | Sci Rep | 2026 | 41922567 | PubTator, text mining | PubMed |
| Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials. | Cancer Immunol Immunother | 2026 | 41915211 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
| Tumor Suppressor p53 and MicroRNAs Interaction in Breast Cancer. | Oncol Res | 2026 | 41799525 | PubTator, text mining | PubMed |
| Catalytic Amplification-Mediated Single-Nanotag Assembly for Sensitive Detection of Circulating microRNAs. | Anal Chem | 2026 | 41773914 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Tauopathies: Mechanisms and Applications. | Int J Mol Sci | 2026 | 41752133 | PubTator, text mining | PubMed |
| Exosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance. | Int J Mol Sci | 2026 | 41752055 | PubTator, text mining | PubMed |
| Mining Potential Therapeutic Targets for T Cell Exhaustion in Osteoarthritis by Integrating Mendelian Randomization and Single-Cell Sequencing. | FASEB J | 2026 | 41603583 | PubTator, text mining | PubMed |
| Cancer cachexia: molecular basis and therapeutic advances. | Signal Transduct Target Ther | 2026 | 41526343 | PubTator, text mining | PubMed |
| The mir-371a-373 cluster: A crucial miRNA cluster promotes the malignancy of gastric cancer. | Neoplasma | 2025 | 41017651 | PubTator, text mining | PubMed |
| Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. | Diabetes Metab Res Rev | 2025 | 40831067 | PubTator, text mining | PubMed |
| Exploring microRNA targeting as a promising approach for solid tumor treatment. | Front Oncol | 2025 | 40761244 | PubTator, text mining | PubMed |
| Chronic stress: a fourth etiology in tumorigenesis? | Mol Cancer | 2025 | 40676620 | PubTator, text mining | PubMed |
| Gene network changes after exposure to nanoliposomes containing antisense miR-21 and miR-373 in bladder cancer Cells: An in vitro model study. | Biochem Biophys Rep | 2025 | 40469776 | PubTator, text mining | PubMed |
| Cascaded logic gate-based electrochemical analysis of multiple miRNAs for cancer recognition. | Biosens Bioelectron | 2025 | 40286645 | PubTator, text mining | PubMed |
| [miR-373 inhibits M2 polarization of tumor associated macrophages and affects rectal cancer cells by regulating JAK2/STAT6 signal pathway]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2025 | 40145452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442918/papers